Biltmore Wealth Management’s Gilead Sciences GILD Stock Holding History

Biltmore Wealth Management’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-5,641	Closed	-$353K	–	58
2018 Q4	$353K	Sell	5,641 -1,508	-21%	-$105K	0.39%	32
2018 Q3	$552K	Buy	7,149 +1,910	+36%	+$144K	0.46%	31
2018 Q2	$371K	Buy	5,239 +3	+0.1%	+$212	0.34%	31
2018 Q1	$395K	Buy	5,236 +241	+5%	+$19.2K	0.37%	30
2017 Q4	$358K	Sell	4,995 -44	-0.9%	-$3.34K	0.32%	31
2017 Q3	$408K	Buy	5,039 +32	+0.6%	+$2.45K	0.43%	29
2017 Q2	$354K	Buy	5,007 +1,840	+58%	+$122K	0.4%	29
2017 Q1	$215K	Buy	3,167 +50	+2%	+$3.52K	0.2%	29
2016 Q4	$223K	Hold	3,117	–	–	0.21%	25
2016 Q3	$247K	Sell	3,117 -490	-14%	-$39.8K	0.22%	26
2016 Q2	$301K	Hold	3,607	–	–	0.25%	23
2016 Q1	$331K	Hold	3,607	–	–	0.28%	26
2015 Q4	$365K	Sell	3,607 -663	-16%	-$69K	0.33%	28
2015 Q3	$419K	Hold	4,270	–	–	0.38%	28
2015 Q2	$500K	Buy	+4,270	New	+$467K	0.42%	30

Other funds holding GILD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Biltmore Wealth Management's GILD Position: Q1 2019 in Review

Biltmore Wealth Management sold out of Gilead Sciences (GILD) in Q1 2019, closing a stake of 5,641 shares — an estimated $353K sold.

Biltmore Wealth Management first reported a position in GILD in Q2 2015 and held it in 15 quarters. The position peaked at $552K in Q3 2018. 1,491 funds tracked by Wall St. Rank hold GILD as of Q1 2019.

Biltmore Wealth Management reported no remaining Gilead Sciences position as of Q1 2019 after selling out during the quarter.
Biltmore Wealth Management sold 5,641 Gilead Sciences shares in Q1 2019, an estimated $353K.
Biltmore Wealth Management first reported a position in Gilead Sciences in Q2 2015 and held it in 15 quarters.
Biltmore Wealth Management's Gilead Sciences position peaked at $552K in Q3 2018.
1,491 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2019.

Based on Biltmore Wealth Management's 13F filing for Q1 2019, filed 8 Apr 2019.